π¬ Cellergy Therapeutics: Transforming Cellular Health Through Mitochondrial Innovation
Our breakthrough approach harnesses the power of young, healthy mitochondria to revolutionize the treatment of degenerative and metabolic diseases.
The Science Behind Our Innovation:
Mitochondria - the cellular powerhouses - are essential for energy production, driving critical functions from muscle contraction to DNA repair. Yet with age, these vital organelles accumulate damage, leading to decreased cellular energy and contributing to various degenerative conditions.
Our Solution:
Through innovative mitochondrial transplantation therapy, we replace compromised mitochondria with fully functional ones, effectively restoring cellular energy production and enhancing cell function.
Target Indications:
Metabolic Disorders
Type 2 Diabetes
Neurodegenerative Diseases
Age-related Conditions
Join us as we advance this transformative technology to address critical unmet medical needs and enhance healthy longevity.
#BiotechInnovation #CellularHealth #Mitochondria #DrugDevelopment #TherapeuticInnovation"
Company Details
- Employees
- 6
- Founded
- -
- Address
- 18 Hakishon, Yavne,center District 8122017,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cellergy-bio.com
- HQ
- Yavne, Center District
Cellergy Therapeutics Questions
Cellergy Therapeutics's website is https://www.cellergy-bio.com
Cellergy Therapeutics's LinkedIn profile is https://il.linkedin.com/company/cellergy-therapeutics
Cellergy Therapeutics has
6 employees.
View email and phone details for 6
employees at Cellergy Therapeutics.
Cellergy Therapeutics's industry is
Biotechnology Research
Cellergy Therapeutics's top competitors are
Converge Bio,
Pharmaseed Ltd,
Coltac Therapeutics,
Minovia Therapeutics,
Sheba Medical Center, Tel Hashomer,
Nevia Bio,
Emendo Biotherapeutics,
Mapi Pharma,
Celluflux Ltd,
Cellergy Pharma Inc..
Cellergy Therapeutics's categories are Biotechnology Research
Cellergy Therapeutics's founding year is 2022
